SCYNEXIS, Inc. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
SCYNEXIS, Inc. (SCYX) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2026-03-04
- SCYNEXIS, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2025 was $600.00K, a 57.14% decline from fiscal 2024.
- SCYNEXIS, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2024 was $1.40M, a 250.00% increase from fiscal 2023.
- SCYNEXIS, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2023 was $400.00K, a 80.95% decline from fiscal 2022.
- SCYNEXIS, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2022 was $2.10M, a 47.50% decline from fiscal 2021.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-03-04 |
| 2024-12-31 | $1.40M 10-K · filed 2026-03-04 |
| 2023-12-31 | $400.00K 10-K · filed 2025-03-12 |
| 2022-12-31 | $2.10M 10-K · filed 2024-03-28 |
| 2021-12-31 | $4.00M 10-K · filed 2023-03-31 |
| 2020-12-31 | $1.70M 10-K · filed 2022-03-29 |
| 2019-12-31 | $1.30M 10-K · filed 2021-03-29 |
| 2018-12-31 | $1.10M 10-K · filed 2020-03-11 |
| 2017-12-31 | $1.80M 10-K · filed 2019-03-14 |
| 2016-12-31 | $1.30M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |